1991
DOI: 10.1288/00005537-199111000-00007
|View full text |Cite
|
Sign up to set email alerts
|

The rhinologic evaluation of alzheimer's disease

Abstract: Olfactory dysfunction is currently not listed among the NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. There is a large amount of psychophysical and neuropathologic evidence to suggest that patients with Alzheimer's type dementia have olfactory system abnormalities. The rhinologic status of this group has not been characterized. The authors examined 21 Alzheimer's patients and 21 age-matched controls to determine whether 1. the Alzheimer's group, in fact, had a diminished sense of sme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

1993
1993
2006
2006

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 31 publications
(9 citation statements)
references
References 19 publications
0
8
0
1
Order By: Relevance
“…Odor identification testing may be sensitive to AD because of early neurofibrillary tangles in the entorhinal cortex, 24,25 b-amyloid deposits in the olfactory bulb regions, 26 or reduced numbers of mitral cells in the olfactory bulb. 27 Pathological functioning of "upstream" structures (e.g., nasal epithelium) are not specific to AD patients, 28,29 and "downstream" areas (e.g., mesial temporal lobe) are only beginning to receive attention for their role in impaired olfaction. 30 Conversely, there is no current neuropathological evidence to suggest that the entorhinal cortex or other olfactory system components would be affected in MD.…”
Section: Discussionmentioning
confidence: 99%
“…Odor identification testing may be sensitive to AD because of early neurofibrillary tangles in the entorhinal cortex, 24,25 b-amyloid deposits in the olfactory bulb regions, 26 or reduced numbers of mitral cells in the olfactory bulb. 27 Pathological functioning of "upstream" structures (e.g., nasal epithelium) are not specific to AD patients, 28,29 and "downstream" areas (e.g., mesial temporal lobe) are only beginning to receive attention for their role in impaired olfaction. 30 Conversely, there is no current neuropathological evidence to suggest that the entorhinal cortex or other olfactory system components would be affected in MD.…”
Section: Discussionmentioning
confidence: 99%
“…The patients with deviated septum had chief complaints of nasal breathing difficulties and/or poor odor sensitivity. Diagnoses were based on 1. computed tomographic scans of the anterior cranial fossa, nasal cavity, and paranasal sinuses, and 2. rhinomanometry, 34 nasal cytology, 35,36 nasal endoscopy, allergic evaluation, and general ear, nose, and throat examination 35,37 . It should be noted that this patient distribution does not reflect the general distribution of patients at chemosensory clinics throughout the United States.…”
Section: Methodsmentioning
confidence: 97%
“…In a recent study, we assessed nasal airway resistance, gross appearance of the nasal cavities and nasal epithelium, and the extent of allergic rhinitis and bacterial infection in Alzheimer's patients and in normal elderly controls to determine their influence on olfactory threshold differences. A summary of these findings can be found in Feldman et al 43 We tested olfactory thresholds for butanol, using the two-alternative, forced-choice, staircase procedure. Nasal airway resistance was calculated from simultaneous measurements of nasal inspiratory flow-rates and pressures, using the active, uninasal, anterior, rhinomanometric technique described in Jalowayski et al 44 We took nasal mucosal samples from the midinferior portion of the inferior turbinate, using a disposable, plastic rhinoprobe.…”
Section: B Nasal Diseasementioning
confidence: 94%